Partial Response to PPI Treatment: The Cost to Society and the Burden to the Patient - a Study in France

Prevalence of Gastroesophageal Reflux During Childhood and Teenage Years in France

NCT00681837 ·Status: COMPLETED

Recurrence Rate, Risk Factors for the Recurrence, and Quality of Life in Patients With GERD in Korea-an Observational

NCT01378338 ·Status: COMPLETED

the Impact of Paediatric Use of Proton Pump Inhibitors on the Risk of Community Acquired Infections.

NCT03134495 ·Status: COMPLETED

National Survey on GERD Patients (Adults and Children)

NCT00833573 ·Status: COMPLETED

Impact of GERD on Daily Life (NIS)

NCT00545883 ·Status: COMPLETED

Structured Treatment of Gastroesophageal Reflux in a Company Health Care Setting, -Effect on Quality of Life, Symptoms and Productivity

NCT00884247 ·Status: COMPLETED

Prospective Evaluation of PH-impedance Tracings According to the Wingate Consensus, and Influence on GERD Classification According to the Lyon Consensus

NCT06084572 ·Status: RECRUITING

Open, Randomised, Multi-center Study of on Demand Versus Continuous Esomeprazole Treatment in Patient With GERD

NCT02670642 ·Status: COMPLETED ·Phase: PHASE3

Symptoms and Management Strategies in Gastroesophageal Reflux Disease (GERD)

NCT00768443 ·Status: COMPLETED

What is the Predictive Value of the Reflux Impact Scale

NCT00536328 ·Status: TERMINATED

Efficacy And Safety Of PF-00885706 For The Relief Of Symptoms In Subjects With Gastro-esophageal Reflux Disease (GERD)

NCT00730665 ·Status: TERMINATED ·Phase: PHASE2

A Cross-sectional Study on the Prevalence and Extraesophageal Symptoms of Gastroesophageal Reflux Disease(GERD) in Patients With Upper GI Symptoms, Visiting the Outpatient Departments of Peripheral Hospitals in Greece

NCT01215305 ·Status: COMPLETED

Symptom Control and Impact on Daily Life in Patients With Gastroesophageal Reflux Disease

NCT01432392 ·Status: COMPLETED

Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Erosive Gastroesophageal Reflux Disease (Phase 2, Therapeutic Exploratory Study)

NCT03184324 ·Status: COMPLETED ·Phase: PHASE2

A Prospective, Observational Study of the PPI Non-responder

NCT03282084 ·Status: WITHDRAWN

PPI Refractory - GERD Mechanisms in Systemic Sclerosis

NCT07022912 ·Status: NOT_YET_RECRUITING

A Study to Estimate Effect of 4 Different Doses of AZD3355 on Reflux Episodes, Which Patients With Gastroesophageal Reflux Disease (GERD) May Experience

NCT01043185 ·Status: COMPLETED ·Phase: PHASE2

A Study in Patients With Erosive Esophagitis to Investigate Safety, Tolerability, and Healing Rates After 4 Weeks Treatment of X842 or Lansoprazole and Symptom Pattern During Subsequent 4 Weeks Treatment With Lansoprazole

NCT05055128 ·Status: COMPLETED ·Phase: PHASE2

Efficacy of Pantoprazole in Patients Older Than 18 Years Who Have Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/M3-339)

NCT00163306 ·Status: COMPLETED ·Phase: PHASE3

Positive Predictive Value of the Dx-pH Probe for Predicting PPI Response in LPR

NCT01755221 ·Status: COMPLETED

An Explorative Trial to Evaluate the Pharmacodynamic Effect of SPD557 on Reflux Parameters in Refractory GERD Patients

NCT01370863 ·Status: TERMINATED ·Phase: PHASE2

National Survey on Gastroesophageal Reflux Disease (GERD) Patients

NCT00695838 ·Status: COMPLETED

The Phase III Clinical Trial of X842 Capsules for Reflux Esophagitis

NCT07079540 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Non Erosive Reflux Disease

NCT03811080 ·Status: UNKNOWN ·Phase: PHASE3

Proton Pump Inhibitor Empirical Treatment in Management of Outpatients With Gastroesophageal Reflux Disease.

NCT02606851 ·Status: COMPLETED